Courts appear to be affirming what pharmacists have long known: compounding GLP-1 medications for patients who can’t access the brand-name versions is a legal, responsible and necessary form of care. In three federal cases — one against a pharmacy and two against telehealth platforms — judges have openly questioned drugmaker Eli Lilly’s campaign to paint […]
Author Archives: Scott Brunner
Scott Brunner, CAE is chief executive officer of The Alliance for Pharmacy Compounding. He wrote this for InsideSources.com.
